Jorge Conde

Insider Reports History

Entity
Individual
Location
C/O Syros Pharmaceuticals, Inc., 620 Memorial Drive, Suite 300, Cambridge, MA
Signature
/s/ William Collins, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jorge Conde:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EQRx, Inc. Director Common Stock 0 $2.21 Nov 9, 2023 By AH Bio Fund III, L.P.
EQRx, Inc. Director Common Stock 0 $2.21 Nov 9, 2023 By AH Bio Fund II, L.P.
EQRx, Inc. Director Common Stock 0 $2.21 Nov 9, 2023 By Andreessen Horowitz LSV Fund II, L.P.
EQRx, Inc. Director Common Stock 0 $2.21 Nov 9, 2023 By Andreessen Horowitz LSV Fund I, L.P.
EQRx, Inc. Director Earn-out Shares 0 Nov 9, 2023 By AH Bio Fund III, L.P.
EQRx, Inc. Director Earn-out Shares 0 Nov 9, 2023 By AH Bio Fund II, L.P.
EQRx, Inc. Director Earn-out Shares 0 Nov 9, 2023 By Andreessen Horowitz LSV Fund I, L.P.

Insider Reports Filed by Jorge Conde

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EQRX EQRx, Inc. Nov 9, 2023 7 $0 4 Nov 9, 2023 Director
EQRX EQRx, Inc. Jan 1, 2023 3 $0 4 Jan 4, 2023 Director
EQRX EQRx, Inc. Dec 17, 2021 7 $50M 4 Dec 21, 2021 Director
EQRX EQRx, Inc. Dec 17, 2021 0 $0 3 Dec 21, 2021 Director